Action Oxford Biomedica - OXB

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

280,50

Prix Achat

278,50

Prix Vente

279,50

Volume échangé

160 167

270,00 Fourchette du Jour 282,50

183,60 Plage de 52 semaines 455,00

Cap du marché

297,223M

Clôture Veille

271,50

Ouverture

270,00

Dernière Transaction

279

(O)

Dernière heure de transaction

Volume financier

443 845p

VWAP

277,1141

Volume moyen (3 m)

177 940

Actions en circulation

105 961 906

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,61

Bénéfice par action (BPA)

-1,74

Chiffre d'affairess

89,54M

Bénéfice net

-184,16M

Secteur

Medicinal Chems,botanicl Pds

Industrie

Medicinal Chems,botanicl Pds

Site Web

www.oxb.com

Siège social

Oxford, Gbr

Fondé

Oxford Biomedica Plc est coté dans le secteur Medicinal Chems,botanicl Pds de la London Stock Exchange avec le ticker OXB. Le dernier cours de clôture d'Oxford Biomedica était de 271,50p. Au cours de la dernière année, les actions de Oxford Biomedica ont été négociées dans une fourchette de prix de 183,60p à 455,00p.

Oxford Biomedica compte actuellement 105 961 906 actions en circulation. La capitalisation boursière d'Oxford Biomedica est de £287,69 million. Oxford Biomedica a un ratio cours/bénéfice (ratio PE) de -1.61.

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC 03 March 2025 OXB Total Voting Rights Oxford, UK - 03 March 2025: OXB (LSE: OXB), a global quality and...

OXB to present at the Leerink Partners Global Healthcare Conference

OXB to present at the Leerink Partners Global Healthcare Conference Oxford, UK – 26 February 2025: OXB (LSE:...

Oxford Biomedica PLC Holding(s) in Company

Oxford Biomedica PLC 20 February 2025 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDFBVT43 Issuer Name...

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-16.5	-5.55555555556	297	304	270	178518	285.66585181	DE
4	-92	-24.6979865772	372.5	398.5	270	274057	325.72375028	DE
12	-126	-30.9963099631	406.5	455	270	177940	365.86215995	DE
26	-50	-15.1285930408	330.5	455	270	179483	385.33574889	DE
52	65.5	30.4651162791	215	455	183.6	202002	326.50289001	DE
156	-360.5	-56.24024961	641	727	164.4	187473	338.42206513	DE
260	-219.5	-43.9	500	1678	164.4	184756	596.48058467	DE

OXB - Frequently Asked Questions (FAQ)

What is the current Oxford Biomedica share price?

The current share price of Oxford Biomedica is 280,50p

How many Oxford Biomedica shares are in issue?

Oxford Biomedica has 105 961 906 shares in issue

What is the market cap of Oxford Biomedica?

The market capitalisation of Oxford Biomedica is GBP 287,69M

What is the 1 year trading range for Oxford Biomedica share price?

Oxford Biomedica has traded in the range of 183,60p to 455,00p during the past year

What is the PE ratio of Oxford Biomedica?

The price to earnings ratio of Oxford Biomedica is -1,61

What is the cash to sales ratio of Oxford Biomedica?

The cash to sales ratio of Oxford Biomedica is 3,3

What is the reporting currency for Oxford Biomedica?

Oxford Biomedica reports financial results in GBP

What is the latest annual turnover for Oxford Biomedica?

The latest annual turnover of Oxford Biomedica is GBP 89,54M

What is the latest annual profit for Oxford Biomedica?

The latest annual profit of Oxford Biomedica is GBP -184,16M

What is the registered address of Oxford Biomedica?

The registered address for Oxford Biomedica is WINDRUSH COURT, TRANSPORT WAY, OXFORD, OX4 6LT

What is the Oxford Biomedica website address?

The website address for Oxford Biomedica is www.oxb.com

Which industry sector does Oxford Biomedica operate in?

Oxford Biomedica operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CPAICapai Plc	0,1175p (40,72%)	901,7M
XTRXtract Resources Plc	0,75p (36,36%)	9,04M
EUAEurasia Mining Plc	7,40p (32,14%)	38,22M
STBSecure Trust Bank Plc	540,00p (28,57%)	560,29k
HAYDHaydale Graphene Industries Plc	0,1325p (20,45%)	60,48M
ONCOncimmune Holdings Plc	1,15p (-27,67%)	662,94k
HRNHornby Plc	14,00p (-26,32%)	847,78k
THRUThruvision Group Plc	0,65p (-23,53%)	36,04M
DISDistil Plc	0,065p (-21,21%)	5,94M
SYMESupply@me Capital Plc	0,003p (-20,00%)	340,56M
UKOGUk Oil & Gas Plc	0,0105p (10,53%)	906,2M
CPAICapai Plc	0,1175p (40,72%)	901,7M
PREMPremier African Minerals Limited	0,01025p (-3,30%)	610,07M
ENETEthernity Networks Ltd	0,0625p (-7,41%)	484,96M
EMEEmpyrean Energy Plc	0,1225p (0,00%)	340,91M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oxford Biomedica Plc (OXB)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Oxford Biomedica Plc

OXB Dernières nouvelles

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

Oxford Biomedica PLC Appointment of New Joint Corporate Broker

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

OXB - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Oxford Biomedica Plc (OXB) Cours

Oxford Biomedica Plc (OXB)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Oxford Biomedica Plc

OXB Dernières nouvelles

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

Oxford Biomedica PLC Appointment of New Joint Corporate Broker

Oxford Biomedica PLC Total Voting Rights

Oxford Biomedica PLC Total Voting Rights

OXB to present at the Leerink Partners Global Healthcare Conference

Oxford Biomedica PLC Holding(s) in Company

OXB’s lentiviral vector manufacturing technology to support Boehringer Ingelheim’s newly initiated Phase I/II trial of first-in-class gene therapy for cystic fibrosis

Oxford Biomedica PLC Standard form for notification of major holdings

Oxford BioMedica shares fall as revenue to stay below 2022 level

Oxford Biomedica PLC Full Year Trading Update and Notice of Results

Appointment of Joint Corporate Broker and Joint Financial Adviser

OXB - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités